Cross-sectional Study to Assess the Handling , Patient Satisfaction, and Preference for Inhalation Devices in Patients With Chronic Obstructive Pulmonary Disease (COPD).
Latest Information Update: 02 Apr 2015
Price :
$35 *
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 07 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Feb 2014 Planned End Date changed from 1 Dec 2013 to 1 Mar 2014.
- 16 Oct 2013 Planned end date changed from 1 Sep 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.